Albert Labs International (XCNQ:ABRT) Long-Term Debt : C$0.01 Mil (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Long-Term Debt?

Albert Labs International's Long-Term Debt for the quarter that ended in Sep. 2023 was C$0.01 Mil.

Albert Labs International's quarterly Long-Term Debt stayed the same from Mar. 2023 (C$0.00 Mil) to Jun. 2023 (C$0.00 Mil) but then increased from Jun. 2023 (C$0.00 Mil) to Sep. 2023 (C$0.01 Mil).

Albert Labs International Long-Term Debt Historical Data

The historical data trend for Albert Labs International's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Long-Term Debt Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Long-Term Debt

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Long-Term Debt	Get a 7-Day Free Trial					-	-	-	-	0.01

Albert Labs International (XCNQ:ABRT) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Albert Labs International Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines